Her practice extends to counseling on drug pricing and government price reporting, HIPAA and privacy matters, counseling on Medicare Part D, developing corporate compliance programs, representing clients in contract negotiations and providing transactional support to her clients. Stephanie is a member of the firm’s Life Sciences Industry Group.
Stephanie represents pharmaceutical manufacturers of both pioneer and generic drugs as well as wholesale distributors of prescription drugs and devices. Her recent work has included:
-
Developing a training program on government price reporting, including ASP, AMP and Best Price, ceiling and sub-ceiling price reporting to support the Public Health Service 340B program and non-FAMP and FCP reporting to FA/FSS for a pharmaceutical manufacturer.
-
Conducting a “gap analysis” related to a pharmaceutical manufacturer’s existing government price reporting methodologies and documentation.
-
Conducting a review of a pharmaceutical manufacturer’s interactions with managed care and pharmacy benefit management customers.
